文献速递气道管理

声门上气道置入与拔除的气溶胶生成定量评估

A quantitative evaluation of aerosol generation during supraglottic airway insertion and removal.
PubMed 文献 · Anaesthesia · 2021-07-20

在超净手术室实时监测0.3-10微米气溶胶,比较声门上气道置入/拔除与潮气呼吸、主动咳嗽的颗粒浓度。置入和拔除产生的气溶胶与潮气呼吸无差异,仅为单次咳嗽的<4%,提示其不构成高气溶胶生成操作。

要点

  • 声门上气道置入/拔除的气溶胶浓度与潮气呼吸无显著差异。
  • 置入/拔除序列产生的气溶胶不足单次咳嗽的4%。
  • 应据此优化感染防控策略,不必按高气溶胶操作过度防护。

核心结论

  • 声门上气道置入/拔除产生的生物气溶胶不比呼吸多,远少于咳嗽。

研究设计与样本

  • 在超净手术室进行实时气溶胶监测(0.3-10微米直径),观察声门上气道置入与拔除过程。

主要发现

  • 背景颗粒浓度中位数(IQR[范围])为1.6(0-3.1[0-4.0]) particles.l-1。
  • 患者潮气呼吸气溶胶浓度为4.0(1.3-11.0[0-44]) particles.l-1,高于背景(p=0.048)。
  • 置入时气溶胶浓度为1.3(1.0-4.2[0-6.2]) particles.l-1(n=11),与潮气呼吸无差异(p=0.31)。
  • 拔除时气溶胶浓度为2.1(0-17.5[0-26.2]) particles.l-1(n=12),与潮气呼吸无差异(p=0.84)。
  • 置入/拔除序列产生的气溶胶<单次咳嗽的4%(咳嗽104(66-169[33-326]) particles.l-1,n=27;p<0.001)。

临床怎么用

  • 声门上气道置入/拔除不应被视为高气溶胶生成操作,可据此调整个人防护等级和病例间等待时间。
  • 关注操作中非呼吸来源颗粒伪影,避免误判气溶胶风险。

局限性

  • 仅监测0.3-10微米直径颗粒,未涵盖其他粒径范围。
  • 样本量较小(置入n=11,拔除n=12)。
  • 发现非呼吸来源气溶胶伪影,可能影响监测准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many guidelines consider supraglottic airway use to be an aerosol-generating procedure. This status requires increased levels of personal protective equipment, fallow time between cases and results in reduced operating theatre efficiency. Aerosol generation has never been quantitated during supraglottic airway use. To address this evidence gap, we conducted real-time aerosol monitoring (0.3-10-µm diameter) in ultraclean operating theatres during supraglottic airway insertion and removal. This showed very low background particle concentrations (median (IQR [range]) 1.6 (0-3.1 [0-4.0]) particles.l-1 ) against which the patient's tidal breathing produced a higher concentration of aerosol (4.0 (1.3-11.0 [0-44]) particles.l-1 , p = 0.048). The average aerosol concentration detected during supraglottic airway insertion (1.3 (1.0-4.2 [0-6.2]) particles.l-1 , n = 11), and removal (2.1 (0-17.5 [0-26.2]) particles.l-1 , n = 12) was no different to tidal breathing (p = 0.31 and p = 0.84, respectively). Comparison of supraglottic airway insertion and removal with a volitional cough (104 (66-169 [33-326]), n = 27), demonstrated that supraglottic airway insertion/removal sequences produced <4% of the aerosol compared with a single cough (p < 0.001). A transient aerosol increase was recorded during one complicated supraglottic airway insertion (which initially failed to provide a patent airway). Detailed analysis of this event showed an atypical particle size distribution and we subsequently identified multiple sources of non-respiratory aerosols that may be produced during airway management and can be considered as artefacts. These findings demonstrate supraglottic airway insertion/removal generates no more bio-aerosol than breathing and far less than a cough. This should inform the design of infection prevention strategies for anaesthetists and operating theatre staff caring for patients managed with supraglottic airways.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Shrimpton AJ, Gregson FKA, Brown JM, et al. A quantitative evaluation of aerosol generation during supraglottic airway insertion and removal. Anaesthesia. 2021. PMID: 34287820. doi:10.1111/anae.15542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。